简介内容:RASP-IN-1 (Compound A), a lipophilic compound, serves as an inhibitor for macular degeneration and exhibits biological activity within the rabbit retina. In a mouse model [1], the administration of 14 C-RASP-IN-1 (10 mg/kg) intraperitoneally yielded a maximum concentration (C max) of μg/g in the posterior eye cup 30 minutes post-treatment.